The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial to evaluate clinical efficacy, pharmacodynamics and exploratory analysis of pemetrexed in relation to MLL4 and UTX alteration status in patients with relapsed/refractory metastatic urothelial carcinoma and other solid tumors.
 
Carolyn Moloney
No Relationships to Disclose
 
Zibo Zhao
No Relationships to Disclose
 
Ali Shilatifard
No Relationships to Disclose
 
Joshua Meeks
Honoraria - Astellas Pharma; AstraZeneca; bristol meyers; CG Oncology; ferring; ImmunityBio; Imvax; Janssen; Merck; Pfizer; Photocure; Prokarium; Protara Therapeutics; Urogen pharma
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
David VanderWeele
Honoraria - Astellas Pharma; Myovant Sciences
Consulting or Advisory Role - Bayer; Janssen
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Curium Pharma (Inst); Fortis (Inst); Harpoon therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Tarik Demir
No Relationships to Disclose
 
Therese Davis Brown
No Relationships to Disclose
 
Ruohui Chen
No Relationships to Disclose
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Foundation Medicine; Guardant Health; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; BMS; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
 
Aparna Kalyan
No Relationships to Disclose
 
Chengwei Peng
No Relationships to Disclose
 
Mary Mulcahy
No Relationships to Disclose
 
Devalingam Mahalingam
No Relationships to Disclose